ARS Wealth Advisors’s Eastman Chemical EMN Stock Holding History

ARS Wealth Advisors’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,189	Closed	-$289K	–	122
2017 Q3	$289K	Buy	+3,189	New	+$271K	0.11%	93

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ARS Wealth Advisors's EMN Position: Q4 2017 in Review

ARS Wealth Advisors sold out of Eastman Chemical (EMN) in Q4 2017, closing a stake of 3,189 shares — an estimated $289K sold.

ARS Wealth Advisors first reported a position in EMN in Q3 2017 and held it in 1 quarter. The position peaked at $289K in Q3 2017. 691 funds tracked by Wall St. Rank hold EMN as of Q4 2017.

ARS Wealth Advisors reported no remaining Eastman Chemical position as of Q4 2017 after selling out during the quarter.
ARS Wealth Advisors sold 3,189 Eastman Chemical shares in Q4 2017, an estimated $289K.
ARS Wealth Advisors first reported a position in Eastman Chemical in Q3 2017 and held it in 1 quarter.
ARS Wealth Advisors's Eastman Chemical position peaked at $289K in Q3 2017.
691 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2017.

Based on ARS Wealth Advisors's 13F filing for Q4 2017, filed 11 Jun 2021.